Form 4: IFF Executive Angela Strzelecki Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Angela Strzelecki, President of Pharma Solutions at International Flavors & Fragrances Inc. (IFF), reported the vesting and settlement of restricted stock units and associated tax withholdings on April 5, 2024.

Summary

  • On April 5, 2024, Angela Strzelecki, President of Pharma Solutions at International Flavors & Fragrances Inc. (IFF), engaged in transactions involving the company's common stock.
  • These transactions included the vesting and settlement of 622 and 518 Restricted Stock Units (RSUs) granted on May 5, 2021, which converted to common stock on a one-for-one basis.
  • Strzelecki also disposed of 161 and 193 shares of common stock to cover taxes payable upon the vesting of the RSUs, at a price of $83.34 per share.
  • Following these transactions, Strzelecki directly owns 7,808 shares of IFF common stock and 2,560 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Comparison to Industry Standards

  • Form 4 filings are standard practice for corporate insiders in publicly traded companies like IFF.
  • Similar filings are made by executives at comparable companies such as Givaudan, Symrise, and Firmenich, disclosing their transactions in company stock.
  • The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934, ensuring transparency in insider trading activities.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect routine executive compensation and stock ownership changes.
  • The filing provides transparency to stakeholders regarding executive stock transactions.

Key Dates

DateDescription
05/05/2021Date the Restricted Stock Units (RSUs) were granted.
04/05/2024Date of the reported transactions: vesting and settlement of RSUs and tax withholding.
04/09/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.